September is World Alzheimer’s Month, and the global Alzheimer’s disease community is looking to raise awareness and combat ...

The FDA has approved Leqembi Iqlik, a subcutaneous, autoinjector formulation for maintenance dosing in people with early Alzheimer's disease ...